RPL23 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.089000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.017200E-01
Normal-vs-Stage2
9.120600E-01
Normal-vs-Stage3
6.326200E-01
Normal-vs-Stage4
5.170600E-01
Stage1-vs-Stage2
4.733400E-01
Stage1-vs-Stage3
8.562400E-01
Stage1-vs-Stage4
2.873200E-01
Stage2-vs-Stage3
4.166400E-01
Stage2-vs-Stage4
4.903400E-01
Stage3-vs-Stage4
2.995600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.044000E-01
Normal-vs-AfricanAmerican
8.252600E-01
Normal-vs-Asian
8.363400E-01
Caucasian-vs-AfricanAmerican
6.535400E-01
Caucasian-vs-Asian
7.898000E-01
AfricanAmerican-vs-Asian
6.523600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.339600E-01
Normal-vs-Female
8.733400E-01
Male-vs-Female
8.259000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.356800E-01
Normal-vs-Age(41-60Yrs)
7.994800E-01
Normal-vs-Age(61-80Yrs)
9.659000E-01
Normal-vs-Age(81-100Yrs)
4.415800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.387200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.873000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.211800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.667800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.700800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.967600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.166200E-01
Normal-vs-Daily Drinker
9.468800E-01
Normal-vs-Weekly Drinker
8.743000E-01
Normal-vs-Occasional Drinker
4.774600E-01
Normal-vs-Social Drinker
7.989000E-01
Non Drinker-vs-Daily Drinker
7.161400E-01
Non Drinker-vs-Weekly Drinker
5.990000E-01
Non Drinker-vs-Occasional Drinker
1.562600E-01
Non Drinker-vs-Social Drinker
4.533800E-01
Daily Drinker-vs-Weekly Drinker
7.981400E-01
Daily Drinker-vs-Occasional Drinker
2.648800E-01
Daily Drinker-vs-Social Drinker
6.393600E-01
Weekly Drinker-vs-Occasional Drinker
6.258000E-01
Weekly Drinker-vs-Social Drinker
8.809600E-01
Occasional Drinker-vs-Social Drinker
7.503200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.732400E-01
Normal-vs-Grade 2
3.864000E-01
Normal-vs-Grade 3
3.996600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.456200E-01
Grade 1-vs-Grade 3
9.816400E-01
Grade 1-vs-Grade 4
4.732400E-01
Grade 2-vs-Grade 3
4.840200E-01
Grade 2-vs-Grade 4
3.864000E-01
Grade 3-vs-Grade 4
3.996600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.452000E-01
Normal-vs-NonDiabetic
8.513000E-01
Diabetic-vs-NonDiabetic
9.680000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.885800E-01
Normal-vs-NoPancreatitis
8.885600E-01
Pancreatitis-vs-NoPancreatitis
4.349000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.422800E-01
Normal-vs-N1
9.416000E-01
N0-vs-N1
5.825400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.718000E-01
Normal-vs-TP53-NonMutant
9.877600E-01
TP53-Mutant-vs-TP53-NonMutant
8.706400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
